Here, by using genetic and pharmacological approaches, we report that colonic expression of ACE2 is induced in response to intestinal inflammation in humans and rodent models of colitis in a GPBAR1-dependent manner and that the GPBAR1–GLP-1 axis mediates this regulation, overcoming inflammation. This evidence concerns the gene ACE2 and colitis.